TrialCirculation2022

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.

Jawad H Butt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.